Research Paper Volume 15, Issue 9 pp 3572—3585
Increased SEMA6B expression as a potential prognostic and immune cell infiltration biomarker in thyroid cancer patients
Figure 4. Diagnostic value analysis of SEMA6B expression in THCA. ROC curve indicated the sensitivity and specificity of SEMA6B expression in THCA subgroup differentiation including TNM staging (A, B), pathologic staging (C, D), primary neoplasm focus (E), extrathyroidal extension (F, G) (n=455).